Tony Fong

Managing Editor, 360Dx

Phone

+1-212-651-5635

Email

[email protected]

Tony Fong is managing editor for 360Dx, GenomeWeb's news site on the in vitro diagnostics market.

Articles Authored by Tony Fong

May 30, 2017

Q&A: Winship Cancer Institute's Dan Brat on the Challenges of Using MDx for Cancer
Premium

Winship's director of the cancer tissue and pathology shared resource said that some labs aren't leveraging molecular technologies due to reimbursement issues.

Tony Fong

Articles Authored by Tony Fong

Q&A: Winship Cancer Institute's Dan Brat on the Challenges of Using MDx for Cancer
Premium

Legend, Janssen Will Invest $150M to Expand Carvykti Manufacturing in Europe

BMS's Breyanzi Gains European Approval as Third-Line Treatment for Follicular Lymphoma

RedHill Biopharma to Launch Phase II Trial of Crohn's Disease Drug in Biomarker-Defined Population

In Brief This Week: Count Me In, TeleRare Health, VolitionRx, Ascentage, Atsena, ClearNote Health

PDS Biotech Cleared to Begin Trial of Immunotherapy Combo in MUC1-Positive Colorectal Cancer

MeiraGTx, Hologen Tackle CNS Disorders With AI Drug Development Joint Venture

Tony Fong

Q&A: Winship Cancer Institute's Dan Brat on the Challenges of Using MDx for Cancer Premium

Legend, Janssen Will Invest $150M to Expand Carvykti Manufacturing in Europe

BMS's Breyanzi Gains European Approval as Third-Line Treatment for Follicular Lymphoma

RedHill Biopharma to Launch Phase II Trial of Crohn's Disease Drug in Biomarker-Defined Population

In Brief This Week: Count Me In, TeleRare Health, VolitionRx, Ascentage, Atsena, ClearNote Health

PDS Biotech Cleared to Begin Trial of Immunotherapy Combo in MUC1-Positive Colorectal Cancer

MeiraGTx, Hologen Tackle CNS Disorders With AI Drug Development Joint Venture

Q&A: Winship Cancer Institute's Dan Brat on the Challenges of Using MDx for Cancer
Premium